https://doi.org/10.4081/monaldi.2020.1596
COVID-19 reinfection - An enigmatic public health threat
Published: November 30, 2020
Abstract Views: 1911
PDF: 920
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
To the Editor
The COVID-19 pandemic has been consistently on the rise across the globe. The recovered patients getting long-term sequelae, especially lung fibrosis and residual neurological deficits, is an area of concern. Another extremely important conundrum is the risk of re-infection. It has been recently documented from Hong Kong and puts an unpleasant question mark on long term immunity, sampling technique standardization, viral mutation and efficacy of herd immunity. There are definitions for COVID -19 infection and its severity, but unfortunately none for re-infection.
How to Cite
Iyengar , Karthikeyan P., Vijay Kumar Jain, and Pranav Ish. 2020. “COVID-19 Reinfection - An Enigmatic Public Health Threat”. Monaldi Archives for Chest Disease 90 (4). https://doi.org/10.4081/monaldi.2020.1596.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Neeta Singla, Amitesh Gupta, U.K. Khalid, Ravindra Kumar Dewan, Rupak Singla, Clinical profile, risk factors, disease severity, and outcome for COVID-19 disease in patients with tuberculosis on treatment under the National Tuberculosis Elimination Program: a cohort of 1400 patients , Monaldi Archives for Chest Disease: Early Access
- Amrutha S, Komaldeep Kaur, Deepak Aggarwal, Mandeep Kaur Sodhi, Shivani Jaswal, Varinder Saini, Serial evaluation of antibody titres in patients recovered from COVID-19 and their correlation with disease severity , Monaldi Archives for Chest Disease: Vol. 94 No. 4 (2024)
- Unnati Desai, Ketaki Utpat, Aravind Raj, The impact of the COVID-19 pandemic on the profile of interstitial lung disease presenting to the pulmonary medicine department of a tertiary care center in western India , Monaldi Archives for Chest Disease: Early Access
- Frederico Ribeiro Neto, Juliane Machado Marques, Matheus Brasiliano da Paz, Eduardo Boiteux Uchôa Cavalcanti, Rodrigo Rodrigues Gomes Costa, Sit-to-stand test and handgrip strength in men and women with post-COVID-19 syndrome without invasive ventilator support: insights from a Brazilian observational study , Monaldi Archives for Chest Disease: Vol. 94 No. 3 (2024)
- Gaukhar Kurmanova, Almas Zhanaev, Akzharkyn Kaldybek, Balkiya Abdrakhmanova, Almira Akparova, Impact of the COVID-19 pandemic on the clinical features of patients with chronic obstructive pulmonary disease: an observational cross-sectional study , Monaldi Archives for Chest Disease: Early Access
- Angelica Cersosimo, Mattia Di Pasquale, Gianmarco Arabia, Marco Metra, Enrico Vizzardi, COVID myocarditis: a review of the literature , Monaldi Archives for Chest Disease: Vol. 94 No. 4 (2024)
- Megha Hegde, Saurav Raj, Dhananjay Tikadar, Sanatkumar B Nyamagoud, Unveiling vaccine safety: a narrative review of pharmacovigilance in India’s COVID-19 vaccination , Monaldi Archives for Chest Disease: Vol. 94 No. 4 (2024)
- Sunny Kumar, Saurabh Mehra, Mrinal Sircar, Onkar Jha, Rajesh Gupta, Seema Sinha, Ravneet Kaur, Evaluation of the efficacy of convalescent plasma in moderate to severe COVID-19 during 2020-2021: a retrospective observational study , Monaldi Archives for Chest Disease: Early Access
- Matteo Vigna, Piero Ceriana, Mara Santomassimo, Michele Vitacca, Mauro Maniscalco, Nicolino Ambrosino, Effects of pulmonary rehabilitation in survivors of severe acute respiratory syndrome coronavirus 2. Role of vaccination , Monaldi Archives for Chest Disease: Vol. 94 No. 3 (2024)
- Federico Raimondi, Stefano Centanni, Fabrizio Luppi, Stefano Aliberti, Francesco Blasi, Paola Rogliani, Claudio Micheletto, Marco Contoli, Alessandro Sanduzzi Zamparelli, Marialuisa Bocchino, Paolo Busatto, Luca Novelli, Simone Pappacena, Luca Malandrino, Giorgio Lorini, Greta Carioli, Fabiano Di Marco, Respiratory rate-oxygenation index on the 3rd day is the best predictor of treatment failure in COVID-19 patients , Monaldi Archives for Chest Disease: Vol. 94 No. 4 (2024)
You may also start an advanced similarity search for this article.
